Skip to Main Content

ABPA is a pulmonary hypersensitivity disorder caused by allergy to fungal antigens that colonize the tracheobronchial tree. It usually occurs in response to antigens of Aspergillus species in atopic asthmatic individuals or those with cystic fibrosis. Primary criteria for the diagnosis of ABPA include (1) a clinical history of asthma or cystic fibrosis; (2) elevated serum total IgE levels (greater than 1000 IU/mL); (3) immediate cutaneous hypersensitivity to Aspergillus antigens or elevated serum IgE levels specific to Aspergillus fumigatus; and (4) at least two of the following: (a) precipitating serum antibodies to Aspergillus antigen or elevated serum Aspergillus IgG by immunoassay, (b) pulmonary radiographic abnormalities consistent with ABPA, or (c) peripheral blood eosinophil count greater than 500 cells/mcL (greater than 0.5 × 109/L). Radiographic abnormalities include transient opacities, mucoid impaction, and proximal or central bronchiectasis. High-dose corticosteroids (eg, prednisone 0.5–1 mg/kg orally per day) for at least 2 weeks with gradual taper is the treatment of choice. Patients with corticosteroid-dependent disease may benefit from itraconazole or voriconazole. Relapses are frequent. For those with frequent exacerbations or unable to wean off steroids, the use of biologic agents, such as anti-IgE (omalizumab), anti-IL-5 (mepolizumab, benralizumab), or anti-IL4 receptor (dupilumab), has been shown to improve outcomes. Bronchodilators (see Table 9–4) may also be helpful. Complications include hemoptysis, severe bronchiectasis, and pulmonary fibrosis.

+
Agarwal  R  et al. Allergic bronchopulmonary aspergillosis. Clin Chest Med. 2022;43:99.
[PubMed: 35236565]  
+
Koutsokera  A  et al. Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis. J Cyst Fibros. 2020;19:119.
[PubMed: 31405730]  
+
Moldoveanu  B  et al. Pulmonary aspergillosis: spectrum of disease. Am J Med Sci. 2021;361:411.
[PubMed: 33563417]  
+
Muthu  V  et al. Diagnostic cutoffs and clinical utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract. 2020;8:579.
[PubMed: 31520840]  

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

  • Create a Free Profile